safety

You have access
First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies
FABIAN KOCKELMANN, URS GIGER-PABST, MEHDI OUAISSI, PETRU BUCUR, SARAH BARBEY, ALEXANDER VON ARDENNE and JÜRGEN ZIEREN

Anticancer Research July 2024, 44 (7) 3043-3050; DOI: https://doi.org/10.21873/anticanres.17117
Open Access
Real-world Efficacy and Safety of Bevacizumab for Advanced or Recurrent Müllerian Cancer: A Single-institutional Experience
TAKESHI FUKUDA, TAKUYA NODA, EIJIRO UCHIKURA, YUICHIRO AWAZU, REIKO TASAKA, KENJI IMAI, MAKOTO YAMAUCHI, TOMOYUKI ICHIMURA, TOMOYO YASUI and TOSHIYUKI SUMI

Anticancer Research July 2023, 43 (7) 3097-3105; DOI: https://doi.org/10.21873/anticanres.16481
You have access
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
CHIARA CICCARESE, ROBERTO IACOVELLI, SEBASTIANO BUTI, FRANCESCA PRIMI, SERENA ASTORE, FRANCESCO MASSARI, MIRIAM GRAZIA FERRARA, GIUSEPPE PALERMO, NAZARIO FOSCHI, VALERIO IACOVELLI, ERNESTO ROSSI, GIOVANNI SCHINZARI, PIERLUIGI BOVE, PIERFRANCESCO BASSI, EMILIO BRIA and GIAMPAOLO TORTORA

Anticancer Research March 2022, 42 (3) 1487-1493; DOI: https://doi.org/10.21873/anticanres.15620
You have access
Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)
ATHANASIOS ALEXOPOULOS, CHARISIOS KARANIKIOTIS, ALEXANDROS ARDAVANIS, IOANNIS BOUKOVINAS, PARISIOS MAKRANTONAKIS, CHRISTOS PAPADIMITRIOU, ATHANASIOS ATHANASIADIS, ANASTASIOS BOUTIS, STYLIANOS GIASSAS, STYLIANOS KAKOLYRIS, GEORGIOS KOUMAKIS, KONSTANTINOS PAPAZISIS, ADAMANTIA PSYRRI, NIKOLAOS ZIRAS, SOFIA BAKA, NIKOLAOS KENTEPOZIDIS and VASILIKI MICHALAKI

Anticancer Research February 2022, 42 (2) 1031-1041; DOI: https://doi.org/10.21873/anticanres.15564
You have access
The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting
MASATSUNE SHIBUTANI, WANG EN, YUKI OKAZAKI, SHINICHIRO KASHIWAGI, TATSUNARI FUKUOKA, YASUHITO ISEKI, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research December 2021, 41 (12) 6211-6216; DOI: https://doi.org/10.21873/anticanres.15440
You have access
Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood Malignancies in the Real-world Setting
RUTH PETTENGELL, THOMAS WOLFF, THOMAS GOEHLER and NICOLA CASCAVILLA

Anticancer Research January 2021, 41 (1) 347-354; DOI: https://doi.org/10.21873/anticanres.14782
You have access
Recurrence-free Survival and Safety of Imatinib in Patients With Gastrointestinal Stromal Tumour (GIST) in Greece
IOANNIS BOUKOVINAS, ATHANASIOS KOTSAKIS, NIKOLAOS ANDROULAKIS, GERASIMOS ARAVANTINOS, VASILIKI MICHALAKI, CHRISTOS CHRISTODOULOU, ANTONIOS AVGERINOS, CHRISTOS PAPANDREOU, VASILIKI SIDIROPOULOU, OLGA KOUSIDOU and PARIS KOSMIDIS

Anticancer Research January 2020, 40 (1) 435-441; DOI: https://doi.org/10.21873/anticanres.13971
You have access
Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model
RACHEL A. CROSSLEY, ALYSSA MATZ, TERRY DEW, ASHLEY KALINAUSKAS, NICOLE FAUCETTE, BRAD POFF, LAWRENCE K. SILBART and MARK A. SUCKOW

Anticancer Research April 2019, 39 (4) 1699-1703; DOI: https://doi.org/10.21873/anticanres.13275
You have access
Significance of Age in Japanese Patients Receiving Sunitinib as First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: Comparative Assessment of Efficacy and Safety between Patients Aged <75 and ≥75 Years
HIDEAKI MIYAKE, RYOTA AKI, YUTO MATSUSHITA, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA

Anticancer Research June 2018, 38 (6) 3593-3599; DOI: https://doi.org/10.21873/anticanres.12633
You have access
Safety of Simultaneous Bilateral Pulmonary Resection for Metastatic Lung Tumors
TAICHI MATSUBARA, GOUJI TOYOKAWA, FUMIHIKO KINOSHITA, NAOKI HARATAKE, YUKA KOZUMA, TAKAKI AKAMINE, SHINKICHI TAKAMORI, FUMIHIKO HIRAI, TETSUZO TAGAWA, TATSURO OKAMOTO and YOSHIHIKO MAEHARA

Anticancer Research March 2018, 38 (3) 1715-1719;

Main menu

User menu

Search

safety

Pages